Literature DB >> 12623132

Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives.

Juan Diego Maya1, Soledad Bollo, Luis J Nuñez-Vergara, Juan A Squella, Yolanda Repetto, Antonio Morello, Jacques Périé, Gérard Chauvière.   

Abstract

With the aim of determining the actual target(s) of nitro-group bearing compounds considered as possible leads for the development of drugs against Chagas' disease, we studied in parallel nitrofurans and nitroimidazoles. We investigated nine representative compounds for the following properties: efficacy on different Trypanosoma cruzi strains, redox cyclers, inhibition of respiration, production of corresponding nitroso derivatives and intracellular thiol scavengers. Our results indicate that nifurtimox and related compounds act as redox cyclers, whereas the most active in the series, the 5-nitroimidazole megazol essentially acts as thiol scavenger particularly for trypanothione, the cofactor for trypanothione reductase, an essential enzyme in the detoxification process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623132     DOI: 10.1016/s0006-2952(02)01663-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  29 in total

1.  Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.

Authors:  Mario Faundez; Laura Pino; Paula Letelier; Carla Ortiz; Rodrigo López; Claudia Seguel; Jorge Ferreira; Mario Pavani; Antonio Morello; Juan Diego Maya
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme.

Authors:  Nahoko Uchiyama; Zakayi Kabututu; Bruno K Kubata; Fumiyuki Kiuchi; Michiho Ito; Junko Nakajima-Shimada; Takashi Aoki; Kei Ohkubo; Shunichi Fukuzumi; Samuel K Martin; Gisho Honda; Yoshihiro Urade
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.

Authors:  Belinda S Hall; Shane R Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

5.  Responsiveness of parasite Cys His proteases to iron redox.

Authors:  Thomas D Lockwood
Journal:  Parasitol Res       Date:  2006-07-06       Impact factor: 2.289

6.  Putrescine analogue cytotoxicity against Trypanosoma cruzi.

Authors:  D Menezes; C Valentim; M F Oliveira; M A Vannier-Santos
Journal:  Parasitol Res       Date:  2005-11-11       Impact factor: 2.289

7.  In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi.

Authors:  K Salomão; E M de Souza; S A Carvalho; E F da Silva; C A M Fraga; H S Barbosa; S L de Castro
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

8.  Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage.

Authors:  Bertin Enanga; Mark R Ariyanayagam; Mhairi L Stewart; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs.

Authors:  Ahmed Al-Qahtani; Yunus M Siddiqui; Adnan A Bekhit; Ola A El-Sayed; Hassan Y Aboul-Enein; Mohammed N Al-Ahdal
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

10.  Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox.

Authors:  Mario Faúndez; Rodrigo López-Muñoz; Gloria Torres; Antonio Morello; Jorge Ferreira; Ulrike Kemmerling; Myriam Orellana; Juan D Maya
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.